Paid Clinical Trials Alabama
Discover 768 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Acceptance and Commitment Therapy for Depressed People With Spinal Cord InjuriesAcceptance and Commitment Therapy for Depressed People With Spinal Cord Injuries
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06233656
Conditions
Depression
Spinal Cord Injuries
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Acceptance and commitment therapy (ACT)
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Sponsor:
University of North Carolina, Chapel Hill
Location:
Code:
NCT03554356
Conditions
Barrett Esophagus
Intestinal Metaplasia
Esophageal Dysplasia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CryoBalloon Focal Ablation System
A Community Health Worker Intervention to Address Adverse Pregnancy OutcomesA Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06353256
Conditions
Preeclampsia Postpartum
Adverse Pregnancy Outcomes
Eligibility Criteria
Sex: Female
Age: 16 - 56
Healthy Volunteers: Accepted
Interventions
usual postpartum care
usual postpartum care + community health worker intervention
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
BMS-986365 vs. Investigator's ChoiceA Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Celgene
Location:
Code:
NCT06764485
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986365
Enzalutamide
Abiraterone
Docetaxel
Predinsone/Prednisolone
Standard Care & BR-ACNon-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Sponsor:
BioStem Technologies
Location:
Code:
NCT06811909
Conditions
Non-infected Venous Leg Ulcer
Venous Leg Ulcer
Venous Insufficiency
Venous Stasis
Venous Reflux
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BR-AC
Standard Care
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
RESTORERESTORE: REducing Future FractureS and Improving OuTcOmes of FRagility FracturE
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06455085
Conditions
Osteoporosis
Osteoporotic Fractures
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Augmented-Fracture Liaison Service Arm
Enhanced Usual Care Arm
BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Sponsor:
Blueprint Medicines Corporation
Location:
Code:
NCT04910685
Conditions
Indolent Systemic Mastocytosis
Monoclonal Mast Cell Activation Syndrome
Smoldering Systemic Mastocytosis
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Elenestinib
Placebo